289 related articles for article (PubMed ID: 16957877)
1. The spectrum of Vogt-Koyanagi-Harada disease in Turkey: VKH in Turkey.
Tugal-Tutkun I; Ozyazgan Y; Akova YA; Sullu Y; Akyol N; Soylu M; Kazokoglu H
Int Ophthalmol; 2007; 27(2-3):117-23. PubMed ID: 16957877
[TBL] [Abstract][Full Text] [Related]
2. The spectrum of Vogt-Koyanagi-Harada disease in Iran.
Hedayatfar A; Hosseini SM; Karimi N; Falavarjani KG; Badie N; Zameni M; Soheilian M
Int Ophthalmol; 2018 Apr; 38(2):443-449. PubMed ID: 28260142
[TBL] [Abstract][Full Text] [Related]
3. Vogt-Koyanagi-Harada disease: clinical and demographic characteristics of patients in a specialized eye hospital in Turkey.
Ozdal P; Ozdamar Y; Yazici A; Teke MY; Ozturk F
Ocul Immunol Inflamm; 2014 Aug; 22(4):277-86. PubMed ID: 24328424
[TBL] [Abstract][Full Text] [Related]
4. The spectrum of Vogt-Koyanagi-Harada disease in Tunisia, North Africa.
Khairallah M; Zaouali S; Messaoud R; Chaabane S; Attia S; Ben Yahia S; Hmidi K
Int Ophthalmol; 2007; 27(2-3):125-30. PubMed ID: 17203358
[TBL] [Abstract][Full Text] [Related]
5. Vogt-Koyanagi-Harada disease in Hispanic patients.
Sukavatcharin S; Tsai JH; Rao NA
Int Ophthalmol; 2007; 27(2-3):143-8. PubMed ID: 17380271
[TBL] [Abstract][Full Text] [Related]
6. Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease.
Vukojević M; Vukojevic N; Vuković A; Rupčić B; Blažević M; Blažević A
Acta Dermatovenerol Croat; 2023 Dec; 31(4):229-231. PubMed ID: 38651852
[TBL] [Abstract][Full Text] [Related]
7. Vogt-Koyanagi-Harada Syndrome in Brazilian Children.
Marquezan MC; Nascimento H; Dalbem D; Muccioli C; Belfort R
Ocul Immunol Inflamm; 2020 Apr; 28(3):402-408. PubMed ID: 31120768
[No Abstract] [Full Text] [Related]
8. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids.
Nakayama M; Keino H; Watanabe T; Okada AA
Br J Ophthalmol; 2019 Feb; 103(2):274-278. PubMed ID: 29666121
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease.
Feng H; Chen W; Yang J; Kong H; Li H; He Y; Wang H
BMC Ophthalmol; 2024 Jun; 24(1):238. PubMed ID: 38849758
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.
Abu El-Asrar AM; Al Tamimi M; Hemachandran S; Al-Mezaine HS; Al-Muammar A; Kangave D
Acta Ophthalmol; 2013 Sep; 91(6):e486-93. PubMed ID: 23575246
[TBL] [Abstract][Full Text] [Related]
12. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
[TBL] [Abstract][Full Text] [Related]
13. The Relationship of Vogt-Koyanagi-Harada Syndrome to Ocular Hypertension and Glaucoma.
Veerappan M; Fleischman D; Ulrich JN; Stinnett SS; Jaffe GJ; Allingham RR
Ocul Immunol Inflamm; 2017 Dec; 25(6):748-752. PubMed ID: 27438521
[TBL] [Abstract][Full Text] [Related]
14. Band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada syndrome.
Yang P; Sun M
Cornea; 2011 Dec; 30(12):1336-40. PubMed ID: 21934492
[TBL] [Abstract][Full Text] [Related]
15. The spectrum of Vogt-Koyanagi-Harada disease in South India.
Murthy SI; Moreker MR; Sangwan VS; Khanna RC; Tejwani S
Int Ophthalmol; 2007; 27(2-3):131-6. PubMed ID: 17318321
[TBL] [Abstract][Full Text] [Related]
16. Vogt-Koyanagi-Harada disease presenting as acute angle closure glaucoma at onset.
Yang P; Liu X; Zhou H; Guo W; Zhou C; Kijlstra A
Clin Exp Ophthalmol; 2011; 39(7):639-47. PubMed ID: 22452682
[TBL] [Abstract][Full Text] [Related]
17. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
Park UC; Cho IH; Lee EK; Yu HG
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1203-1211. PubMed ID: 28382438
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and classification of Vogt-Koyanagi-Harada disease.
Sakata VM; da Silva FT; Hirata CE; de Carvalho JF; Yamamoto JH
Autoimmun Rev; 2014; 13(4-5):550-5. PubMed ID: 24440284
[TBL] [Abstract][Full Text] [Related]
19. Vogt-koyanagi-harada disease with onset in elderly patients aged 68 to 89 years.
Yamamoto Y; Fukushima A; Nishino K; Koura Y; Komatsu T; Ueno H
Jpn J Ophthalmol; 2007; 51(1):60-3. PubMed ID: 17295144
[TBL] [Abstract][Full Text] [Related]
20. Analysis of 87 cases with Vogt-Koyanagi-Harada disease.
Mondkar SV; Biswas J; Ganesh SK
Jpn J Ophthalmol; 2000; 44(3):296-301. PubMed ID: 10913650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
